Physician profile

Matthew Allswede

Obstetrics & Gynecology · Lansing, MI

NPI 1790792331

$494.50

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$29.30

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Hologic Sales and Service, LLC $163.03 2019-2020
Abbvie INC. $118.09 2020-2023 Orilissa
Aspira Women'S Health INC $70.49 2022
Minerva Surgical, INC $67.94 2019-2023
Ethicon US, LLC $22.99 2019
Channel Medsystems, INC. $20.03 2022
Covidien LP $12.26 2019
Pfizer INC. $11.50 2019
Alydia Health $8.17 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Matthew Allswede

$494.50

in general payments reported 2019-2025

Years
2019-2023
Top company
Hologic Sales and Service, LLC

https://glasscript.com/doctor/308750/matthew-allswede

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.